++
+++
Essentials of Diagnosis
++
Asymptomatic in approximately 20–35% of adults and most children
When symptomatic, adults often have upper respiratory tract illness with fever and cough
Advanced pulmonary complications (pneumonia, acute respiratory distress syndrome [ARDS]) occur with fulminant disease
Mortality of 1–21% (varied by geographic area and strain)
High predilection for the elderly, the immunocompromised, those with chronic diseases, those living in crowded conditions
+++
General Considerations
++
++
Most infected individuals are asymptomatic
Adults can manifest a wide range of symptoms from mild to severe illness that typically begin 2–14 days after exposure
Symptomatic patients may have cough, fever, chills/rigors, or myalgias
The presence of dyspnea is variable, but it is common in severe infection
No one symptom should be used as a discriminant for disease
Less frequent symptoms include rhinitis, pharyngitis, abdominal symptoms such as nausea and diarrhea, headaches, anosmia and cacosmia, and ageusia and cacogeusia
It appears that 15–20% of adults require hospitalization and 3–5% require critical care
+++
Differential Diagnosis
++
Upper respiratory infection
Seasonal influenza infection
Secondary hemophagocytic lymphohistiocytosis
++
Neutrophilia, absolute lymphopenia, and an increased neutrophil to lymphocyte ratio
Elevated liver biochemical tests and total bilirubin
Serum markers of systemic inflammation are increased
Lactate dehydrogenase
Ferritin
C-reactive protein
Procalcitonin
Interleukin 6 (IL-6)
A coagulopathy often is seen
Elevated von Willebrand factor (VWF) antigen
Elevated D-dimer
Fibrinogen levels are higher than in disseminated intravascular coagulation
++